Key Takeaways
- Mehtaz Sultan Khan has been appointed as the new General Manager for Novo Nordisk in Pakistan.
- His appointment follows the launch of an innovative obesity therapy by the company earlier this year.
- Khan brings over 15 years of leadership experience across healthcare and consumer goods.
Novo Nordisk, a global healthcare company with expertise in diabetes care and expanding focus on obesity, has appointed Mehtaz Sultan Khan as its General Manager for Pakistan. Effective from August 3, 2026, Khan will lead the operations of Novo Nordisk in the country.
Khan’s appointment comes at a critical time for both Novo Nordisk and Pakistan's healthcare landscape, following the launch of an innovative obesity therapy by the company earlier this year. The move underscores Novo Nordisk’s commitment to expanding access to care for people living with chronic diseases in Pakistan.
With over 15 years of leadership experience across healthcare and consumer goods, Khan has held key roles at companies such as Abbott Nutrition International (Pakistan & Iraq), Reckitt, Nestlé, Almarai, and Shan Foods. His expertise includes commercial strategy, brand building, portfolio management, and business transformation.
Speaking about his new role, Khan stated: 'I am excited to join Novo Nordisk at an important time for both the company and Pakistan’s healthcare landscape. As the burden of diabetes and obesity continues to rise, there is a significant opportunity to improve patient outcomes through innovation, stronger partnerships, and greater disease awareness.'
Burak Cem, Vice President of Novo Nordisk Business Area Middle East and Central Asia (BAMECA), expressed his confidence in Khan’s abilities. He said: 'Pakistan is an important market for Novo Nordisk. Mehtaz brings strong experience, and a good understanding of the local healthcare landscape. His experience will be instrumental as we continue expanding access to innovative therapies and strengthening our partnerships across Pakistan.'
Novo Nordisk has been operating in Pakistan for decades, investing in the country’s healthcare ecosystem through scientific innovation, disease awareness, and collaboration with healthcare stakeholders.
The company continues to focus on addressing the growing burden of diabetes and obesity in Pakistan. Khan's appointment is expected to play a crucial role in advancing these efforts.
I am excited to join Novo Nordisk at an important time for both the company and Pakistan’s healthcare landscape.
Mehtaz Sultan Khan, General Manager, Novo Nordisk Pakistan
Pakistan is an important market for Novo Nordisk. Mehtaz brings strong experience, and a good understanding of the local healthcare landscape. His experience will be instrumental as we continue expanding access to innovative therapies and strengthening our partnerships across Pakistan.
Burak Cem, Vice President, Novo Nordisk Business Area Middle East and Central Asia (BAMECA)
